Evidence map›Paper›PMID 26009706›Full record

ArticleCurrent treatment options in psychiatry2015

Use of Preclinical Drug vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction.

Matthew L Banks, Blake A Hutsell, Kathryn L Schwienteck, S Stevens Negus

Open access · bronzeAbstract read
In one paragraph

Article in Current treatment options in psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Effects of naltrexone on amphetamine choice in rhesus monkeys and rats.Experimental and clinical psychopharmacology · 2023
    Article
  8. Environmental Uncertainty and Substance Use Disorders: A Behavior Analytic Perspective.Policy insights from the behavioral and brain sciences · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Medications Development for Treatment of Opioid Use Disorder.Cold Spring Harbor perspectives in medicine · 2021
    Review
  13. Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Review
  14. Review
  15. Article
  16. Behavioral preference for viewing drugPsychological medicine · 2020
    Article
  17. The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research.Handbook of experimental pharmacology · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthew L BanksDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA ; Institute for Drug and Alcohol Abuse Studies, Virginia Commonwealth University, Richmond, VA, USA.
Blake A HutsellDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Kathryn L SchwienteckDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA ; School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.
S Stevens NegusDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA ; Institute for Drug and Alcohol Abuse Studies, Virginia Commonwealth University, Richmond, VA, USA.
Virginia Commonwealth University · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
Medications Development for Stimulant AbuseR01DA026946 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI NEGUS, SIDNEY S · 2009 to 2019
$3.7M
NIDA NIH HHS R01 DA026946NIDA NIH HHS T32 DA007027
6 · The paper itself

Abstract

Drug addiction is a disease that manifests as an inappropriate allocation of behavior towards the procurement and use of the abused substance and away from other behaviors that produce more adaptive reinforcers (e.g. exercise, work, family and social relationships). The goal of treating drug addiction is not only to

Indexed as

addictionchoicemedicationnonhuman primatepreclinical model

Identifiers

PMID26009706
PMCPMC4441409
OpenAlexW2057119584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.